Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-16-110185
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-23 14:14:03
Reporting Period:
2016-03-23
Filing Date:
2016-03-23
Accepted Time:
2016-03-23 14:14:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1616543 Senseonics Holdings Inc. SENS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270735 A Douglas Roeder C/o Delphi Ventures
160 Bovet Road, Suite 408
San Mateo CA 94402
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-23 1,216,195 $2.85 11,237,221 No 4 P Indirect Delphi Ventures VIII, L.P.
Common Stock Acquisiton 2016-03-23 11,875 $2.85 109,725 No 4 P Indirect Delphi BioInvestments VIII, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Delphi Ventures VIII, L.P.
No 4 P Indirect Delphi BioInvestments VIII, L.P.
Footnotes
  1. The securities are directly held by Delphi Ventures VIII, L.P. ("DV VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of DV VIII and may be deemed to have sole voting and dispositive power over the securities held by DV VIII. The Reporting Person is a managing member of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DV VIII. The Reporting Person disclaims beneficial ownership of the securities held by DV VIII, except to the extent of any pecuniary interest therein.
  2. The securities are directly held by Delphi BioInvestments VIII, L.P. ("DBI VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of DBI VIII and may be deemed to have sole voting and dispositive power over the securities held by DBI VIII. The Reporting Person is a managing member of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DBI VIII. The Reporting Person disclaims beneficial ownership of the securities held by DBI VIII, except to the extent of any pecuniary interest therein.